Accepted for/Published in: JMIR Pediatrics and Parenting
Date Submitted: Nov 7, 2021
Open Peer Review Period: Nov 7, 2021 - Jan 2, 2022
Date Accepted: Jul 16, 2022
(closed for review but you can still tweet)
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Positive Choices: Evaluation of a national initiative to disseminate evidence-based alcohol and other drug prevention strategies
ABSTRACT
Background:
To prevent adolescents from initiating alcohol and other drug (AOD) use, and reduce associated harms, effective strategies need to be implemented. Despite their availability, effective school-based programs and evidence informed parental guidelines are not consistently implemented. The Positive Choices drug prevention initiative and website was launched to address this research and practice gap. The intended end users were school staff, parents, and school students. An 8-month post-launch evaluation of the website showed that end users generally had positive feedback on the website’s usability, and following its use the majority would consider the evidence-base and effectiveness of drug education resources. The current study extends this initial evaluation by examining the effectiveness and impact of the Positive Choices initiative over a three-year period.
Objective:
Guided by the five dimensions of the RE-AIM framework i.e., reach, effectiveness, adoption, implementation, and maintenance, the study assesses the impact and effectiveness of the Positive Choices initiative in increasing awareness and implementation of evidence-based drug prevention.
Methods:
Data was collected between 2017 and 2019 using online website evaluation and community awareness surveys. Data from the surveys was merged to examine reach, effectiveness, adoption, implementation, and maintenance, via descriptive statistics. Google Analytics was used to further understand the reach of the website. The System Usability Scale was used to measure website usability. Additionally, inductive analysis was employed to assess participants’ feedback about Positive Choices.
Results:
Five years post-launch, the Positive Choices website has reached >2 million users. A national Australian campaign increased awareness from 8% to 14% post campaign among school staff, and from 15% to 22% among parents. Following a brief interaction with the website the majority of participants, who were not already following recommended strategies, reported an intention to shift towards evidence-based practices. The System Usability Scale score for the website was ‘good’, for both user groups. The participants intended to maintain their use of the Positive Choices website in the future. Both user groups reported a high level of confidence in communicating about AOD related topics. Participants’ suggestions for improvement informed a recent website update.
Conclusions:
The Positive Choices website has the capacity to be an effective strategy for disseminating evidence-based drug prevention information and resources widely. The findings highlight the importance of investing in ongoing maintenance of, and promotion to enhance awareness of health websites. With the increased use and acceptability of health education websites, teams should ensure that websites are easy to navigate, engaging, use simple language, contain evidence-informed resources, and are supported by ongoing promotional activities.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.